Moderna COVID-19 vaccine: Authorized with conditions

Due to the urgent public health needs relating to COVID-19, we can issue a market authorization with conditions. This is done to support early access to promising health products when the potential benefits outweigh the potential risks.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:45 (UTC)
Created April 17, 2026, 21:45 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2021-06-25 00:00:00
open_canada_keywords {"fr": ["COVID-19", "pandémie", "vaccin Moderna COVID-19", "besoins urgents de santé publique", "autorisation de mise sur le marché", "autorisé sous conditions"], "en": ["COVID-19", "pandemic", "Moderna COVID-19 vaccine", "urgent public health needs", "market authorization", "authorized with conditions"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Vaccin de Moderna contre la COVID-19 : Autorisation de mise en marché avec conditions
update_frequency as_needed